Literature DB >> 24993467

The value of comparing mortality of Guillain-Barré syndrome across different regions.

A H Y Wong1, T Umapathi2, N Shahrizaila3, Y C Chan4, N Kokubun5, M K Fong6, Y P Chu6, P K Lau7, N Yuki8.   

Abstract

OBJECTIVE: To study the clinical profile of Guillain-Barré syndrome (GBS) patients who died in 4 Asian countries in order to understand factors underlying any variation in mortality.
METHODS: Retrospectively reviewed medical records of GBS patients who died in 7 hospitals from 4 Asian countries between 2001 and 2012. Baseline characteristics, timing and causes of death were recorded.
RESULTS: A total of 16 out of 261 GBS patients died. The overall mortality rate was 6%, with a range of 0 to 13%. The leading causes of death were respiratory infections, followed by myocardial infarction. The median age of our patients was 77 years. Half of the patients required mechanical ventilation and almost all had significant concomitant illnesses. A disproportionate number of patients in the Hong Kong cohort died (13%). Patients with advanced age, fewer antecedent respiratory infections and need for mechanical ventilation were at most risk. Most deaths occurred during the plateau phase of GBS and on the general ward after having initially received intensive care.
CONCLUSIONS: There is considerable variability in mortality of GBS among different Asian cohorts. Although the risks factors for mortality were similar to Western cohorts, the timing and site of death differed. This allows specific measures to be implemented to improve GBS care in countries with higher mortality.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Asian; Guillain–Barré syndrome; Mortality; Neuropathy; Predictors; Prognosis

Mesh:

Year:  2014        PMID: 24993467     DOI: 10.1016/j.jns.2014.06.021

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  11 in total

1.  Heart rate variability and baroreflex sensitivity abnormalities in Guillain-Barré syndrome: a pilot study.

Authors:  Cheng-Yin Tan; Nortina Shahrizaila; Kee-Ying Yeoh; Khean-Jin Goh; Maw-Pin Tan
Journal:  Clin Auton Res       Date:  2018-04-13       Impact factor: 4.435

2.  Incidence of Guillain-Barré syndrome (GBS) in China: A national population-based study.

Authors:  Pei Zheng; De-Cai Tian; Yuwen Xiu; Yongjun Wang; Fu-Dong Shi
Journal:  Lancet Reg Health West Pac       Date:  2021-11-02

3.  Mortality and disability reported after immunoglobulins or plasmapheresis treatment of Guillain-Barré syndrome.

Authors:  Edinson Dante Meregildo-Rodriguez; Victor Hugo Bardales-Zuta
Journal:  Infez Med       Date:  2021-12-10

4.  Is Agomelatine Associated with Less Sedative-Hypnotic Usage in Patients with Major Depressive Disorder? A Nationwide, Population-Based Study.

Authors:  Shih-Chun Hsing; Yo-Ting Jin; Nian-Sheng Tzeng; Chi-Hsiang Chung; Tien-Yu Chen; Hsin-An Chang; Yu-Chen Kao; Wu-Chien Chien
Journal:  Neuropsychiatr Dis Treat       Date:  2020-07-22       Impact factor: 2.570

5.  Long-term outcomes of Guillain-Barré syndrome possibly associated with Zika virus infection.

Authors:  Diana M Walteros; Jesus Soares; Ashley R Styczynski; Joseph Y Abrams; Jose I Galindo-Buitrago; Jorge Acosta-Reyes; Elsa Bravo-Ribero; Zuleima E Arteta; Alma Solano-Sanchez; Franklyn E Prieto; Maritza Gonzalez-Duarte; Edgar Navarro-Lechuga; Jorge L Salinas; Ermias D Belay; Lawrence B Schonberger; Inger K Damon; Martha L Ospina; James J Sejvar
Journal:  PLoS One       Date:  2019-08-01       Impact factor: 3.240

6.  Incidence of Guillain-Barré Syndrome (GBS) in Latin America and the Caribbean before and during the 2015-2016 Zika virus epidemic: A systematic review and meta-analysis.

Authors:  Ariadna Capasso; Danielle C Ompad; Dorice L Vieira; Annelies Wilder-Smith; Yesim Tozan
Journal:  PLoS Negl Trop Dis       Date:  2019-08-26

7.  Stimulants associated with reduced risk of hospitalization for motor vehicle accident injury in patients with obstructive sleep apnea-a nationwide cohort study.

Authors:  Yi-Chang Lin; Tien-Yu Chen; Wu-Chien Chien; Chi-Hsiang Chung; Hsin-An Chang; Yu-Chen Kao; Chien-Sung Tsai; Chih-Sheng Lin; Nian-Shen Tzeng
Journal:  BMC Pulm Med       Date:  2020-02-03       Impact factor: 3.317

8.  Clinical profile and predictors for outcome in children presenting with Guillain-Barré syndrome.

Authors:  Sonali Singh; Nitin Gupta; Arpita M Gupta; Anurag S Chandel; Sneha Waghela; Pallavi Saple
Journal:  J Family Med Prim Care       Date:  2020-10-30

9.  Increased rates of Guillain-Barré syndrome associated with Zika virus outbreak in the Salvador metropolitan area, Brazil.

Authors:  Ashley R Styczynski; Juliane M A S Malta; Elisabeth R Krow-Lucal; Jadher Percio; Martha E Nóbrega; Alexander Vargas; Tatiana M Lanzieri; Priscila L Leite; J Erin Staples; Marc X Fischer; Ann M Powers; Gwong-Jen J Chang; P L Burns; Erin M Borland; Jeremy P Ledermann; Eric C Mossel; Lawrence B Schonberger; Ermias B Belay; Jorge L Salinas; Roberto D Badaro; James J Sejvar; Giovanini E Coelho
Journal:  PLoS Negl Trop Dis       Date:  2017-08-30

10.  Increased Risk of Psychiatric Disorders in Allergic Diseases: A Nationwide, Population-Based, Cohort Study.

Authors:  Nian-Sheng Tzeng; Hsin-An Chang; Chi-Hsiang Chung; Yu-Chen Kao; Chuan-Chia Chang; Hui-Wen Yeh; Wei-Shan Chiang; Yu-Ching Chou; Shan-Yueh Chang; Wu-Chien Chien
Journal:  Front Psychiatry       Date:  2018-04-24       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.